Trial Profile
The Vascular Inflammation Imaging Using Somatostatin Receptor Positron Emission Tomography Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Gallium 68-DOTATATE (Primary) ; Fludeoxyglucose F-18
- Indications Atherosclerosis; Carotid stenosis; Inflammation
- Focus Diagnostic use
- 19 Apr 2017 New trial record
- 11 Apr 2017 Results published in the Journal of the American College of Cardiology